Banca de DEFESA: RODIENE MORAES PINTO DA SILVA

Uma banca de DEFESA de MESTRADO foi cadastrada pelo programa.
STUDENT : RODIENE MORAES PINTO DA SILVA
DATE: 02/06/2025
TIME: 14:30
LOCAL: BLOCO DA PÓS GRADUAÇÃO
TITLE:

HEPATITES B E C: ASPECTOS CLÍNICOS, LABORATORIAIS,
EPIDEMIOLÓGICOS E FATORES ASSOCIADOS NO AMAPÁ

KEY WORDS:

 

 

Hepatite B. Hepatite C. Vírus. Saúde Pública. Infecções.

PAGES: 100
BIG AREA: Ciências da Saúde
AREA: Saúde Coletiva
SUMMARY:

Introduction: Viral hepatitis is an infection caused by different viruses that affect the
liver. The infection is usually silent, increasing the problem of early detection and
treatment. Objective: To describe the clinical, laboratory and epidemiological aspects
and factors associated with cases of hepatitis B and C treated at the Reference Center for
Tropical Diseases in the state of Amapá. Material and methods: We opted for an
exploratory, descriptive methodology with a quantitative and qualitative approach. Data
collection was carried out by searching documents, medical records, epidemiological
bulletins and others that deal with the subject, from 2013 to 2023, 254 medical records
were analyzed of hepatitis B and C patients who have treated or are still being treated, for
the qualitative study took place through the application of a semi-structured interview, in
which eight patients who accepted the terms of the research and who are being treated for
hepatitis B and hepatitis C in the reference unit of the state of Amapá were interviewed.
Quantitative data analysis was carried out using Microsoft Excel 2019 software and
Statistical Package for the Social Sciences software version 26. The variables were
subjected to the Kolmogorov-Smirnov normality test to check whether they were suitable
for parametric tests, Pearson's chi-square association test to detect associations between
responses and variables and the Content Analysis method, with the support of ATLAS.ti®
software version 25 in relation to qualitative analysis for the management of coded data.
Preliminary results: 2019 showed the highest percentage of patients starting treatment
for viral hepatitis (17.9%), followed by 2021 (14.3%) and 2017 (12.3%) (Table 1). In
addition, based on the qualitative analysis, 164 citations were identified in the textual
corpus, emotions and feelings 34 (20.73%), adversities encountered 28 (17.07%),
treatment 26 (15.85%), discovery and talk of diagnosis 21 (12.80%), professional health
guidance 16 (9.75%), viabilities encountered 16 (9.75%), family dynamics 11 (6.70%),
had no knowledge 8 (4.87%), knowledge of the disease 4 (2.43%). Initial considerations: The evidence presented leads us to conclude that care for viral hepatitis, especially B and C, is fragile when it comes to monitoring patients, both in terms of trained professionals, laboratories and diagnostic tests, as well as sociais issues and the well-being of those affected by the disease. Other associated factors, such as fear, anxietyand lack of financial resources to meet needs, are factors that have an impact on life and  the success of treatment. In view of the above, there is an urgent need to expand accessto comprehensive care for users with viral hepatitis and timely investigations to discover the disease in order to promote early treatment to avoid severe complications. It is essential that health professionals have ownership of the line of care and finally that the difficulties of decentralizing this care are overcome.

COMMITTEE MEMBERS:
Interna - 2269975 - CAMILA RODRIGUES BARBOSA NEMER
Interna - 1015007 - MARLUCILENA PINHEIRO DA SILVA
Externa ao Programa - 443863 - NELY DAYSE SANTOS DA MATA - nullPresidente - 2269635 - RUBENS ALEX DE OLIVEIRA MENEZES